Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Sage Therapeutics Inc has a consensus price target of $13.33 based on the ratings of 23 analysts. The high is $49 issued by Citigroup on May 3, 2023. The low is $4 issued by RBC Capital on November 21, 2024. The 3 most-recent analyst ratings were released by Scotiabank, Wedbush, and Canaccord Genuity on February 12, 2025, respectively. With an average price target of $8.67 between Scotiabank, Wedbush, and Canaccord Genuity, there's an implied 1.90% upside for Sage Therapeutics Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
02/12/2025 | Buy Now | 41.09% | Scotiabank | George Farmer48% | $14 → $12 | Maintains | Sector Outperform | Get Alert |
02/12/2025 | Buy Now | -29.45% | Wedbush | Laura Chico48% | $6 → $6 | Reiterates | Neutral → Neutral | Get Alert |
02/12/2025 | Buy Now | -5.94% | Canaccord Genuity | Sumant Kulkarni45% | $9 → $8 | Maintains | Hold | Get Alert |
02/12/2025 | Buy Now | 41.09% | HC Wainwright & Co. | Douglas Tsao53% | $14 → $12 | Reiterates | Neutral → Neutral | Get Alert |
02/12/2025 | Buy Now | — | Needham | Ami Fadia62% | — | Reiterates | Hold → Hold | Get Alert |
01/02/2025 | Buy Now | 5.82% | Piper Sandler | David Amsellem69% | $26 → $9 | Maintains | Overweight | Get Alert |
12/16/2024 | Buy Now | -29.45% | Stifel | Paul Matteis43% | $10 → $6 | Maintains | Hold | Get Alert |
11/21/2024 | Buy Now | 5.82% | TD Cowen | Ritu Baral36% | $10 → $9 | Maintains | Hold | Get Alert |
11/21/2024 | Buy Now | -52.97% | RBC Capital | Brian Abrahams52% | $4 → $4 | Upgrade | Underperform → Sector Perform | Get Alert |
11/20/2024 | Buy Now | 64.61% | HC Wainwright & Co. | Douglas Tsao53% | $14 → $14 | Reiterates | Neutral → Neutral | Get Alert |
11/20/2024 | Buy Now | — | Needham | Ami Fadia62% | — | Reiterates | → Hold | Get Alert |
10/30/2024 | Buy Now | 64.61% | Scotiabank | George Farmer48% | $17 → $14 | Maintains | Sector Outperform | Get Alert |
10/30/2024 | Buy Now | 205.7% | Piper Sandler | Yasmeen Rahimi61% | $52 → $26 | Reiterates | Overweight → Overweight | Get Alert |
10/30/2024 | Buy Now | -5.94% | Oppenheimer | Jay Olson62% | $9 → $8 | Maintains | Perform | Get Alert |
10/30/2024 | Buy Now | -5.94% | Truist Securities | Joon Lee78% | $13 → $8 | Maintains | Hold | Get Alert |
10/30/2024 | Buy Now | 64.61% | HC Wainwright & Co. | Douglas Tsao53% | $25 → $14 | Maintains | Neutral | Get Alert |
10/30/2024 | Buy Now | — | Needham | Ami Fadia62% | — | Reiterates | → Hold | Get Alert |
10/17/2024 | Buy Now | — | Needham | Ami Fadia62% | — | Reiterates | → Hold | Get Alert |
10/10/2024 | Buy Now | — | Raymond James | Danielle Brill43% | — | Reinstates | → Market Perform | Get Alert |
10/09/2024 | Buy Now | -29.45% | B of A Securities | Tazeen Ahmad56% | $11 → $6 | Maintains | Underperform | Get Alert |
10/09/2024 | Buy Now | -5.94% | Wedbush | Laura Chico48% | $9 → $8 | Maintains | Neutral | Get Alert |
10/09/2024 | Buy Now | 5.82% | Baird | Joel Beatty69% | $13 → $9 | Maintains | Neutral | Get Alert |
10/09/2024 | Buy Now | 193.94% | HC Wainwright & Co. | Douglas Tsao53% | $25 → $25 | Reiterates | Neutral → Neutral | Get Alert |
10/08/2024 | Buy Now | — | Needham | Ami Fadia62% | — | Reiterates | → Hold | Get Alert |
10/04/2024 | Buy Now | -52.97% | RBC Capital | Brian Abrahams52% | $10 → $4 | Downgrade | Sector Perform → Underperform | Get Alert |
08/14/2024 | Buy Now | 52.85% | Truist Securities | Joon Lee78% | $18 → $13 | Maintains | Hold | Get Alert |
08/06/2024 | Buy Now | 17.58% | JP Morgan | Anupam Rama60% | $12 → $10 | Maintains | Neutral | Get Alert |
08/02/2024 | Buy Now | 193.94% | HC Wainwright & Co. | Douglas Tsao53% | $25 → $25 | Reiterates | Neutral → Neutral | Get Alert |
08/01/2024 | Buy Now | 511.41% | Piper Sandler | Yasmeen Rahimi61% | $70 → $52 | Maintains | Overweight | Get Alert |
08/01/2024 | Buy Now | — | Needham | Ami Fadia62% | — | Reiterates | → Hold | Get Alert |
07/30/2024 | Buy Now | 17.58% | TD Cowen | Ritu Baral36% | $16 → $10 | Downgrade | Buy → Hold | Get Alert |
07/26/2024 | Buy Now | 29.34% | Goldman Sachs | Salveen Richter53% | $19 → $11 | Maintains | Neutral | Get Alert |
07/25/2024 | Buy Now | 99.88% | Scotiabank | George Farmer48% | $19 → $17 | Maintains | Sector Outperform | Get Alert |
07/25/2024 | Buy Now | 41.09% | JP Morgan | Anupam Rama60% | $18 → $12 | Downgrade | Overweight → Neutral | Get Alert |
07/25/2024 | Buy Now | 52.85% | Baird | Joel Beatty69% | $15 → $13 | Maintains | Neutral | Get Alert |
07/25/2024 | Buy Now | 193.94% | HC Wainwright & Co. | Douglas Tsao53% | $25 → $25 | Reiterates | Neutral → Neutral | Get Alert |
07/24/2024 | Buy Now | — | Needham | Ami Fadia62% | — | Reiterates | → Hold | Get Alert |
07/19/2024 | Buy Now | 88.12% | Mizuho | Uy Ear63% | $18 → $16 | Maintains | Neutral | Get Alert |
07/12/2024 | Buy Now | 111.64% | JP Morgan | Anupam Rama60% | $23 → $18 | Maintains | Overweight | Get Alert |
07/02/2024 | Buy Now | 193.94% | HC Wainwright & Co. | Douglas Tsao53% | $25 → $25 | Reiterates | Neutral → Neutral | Get Alert |
06/28/2024 | Buy Now | — | Needham | Ami Fadia62% | — | Reiterates | → Hold | Get Alert |
06/20/2024 | Buy Now | 170.43% | JP Morgan | Anupam Rama60% | $28 → $23 | Maintains | Overweight | Get Alert |
06/12/2024 | Buy Now | 193.94% | HC Wainwright & Co. | Douglas Tsao53% | $25 → $25 | Reiterates | Neutral → Neutral | Get Alert |
06/11/2024 | Buy Now | — | Needham | Ami Fadia62% | — | Reiterates | → Hold | Get Alert |
06/11/2024 | Buy Now | 76.37% | Baird | Joel Beatty69% | $15 → $15 | Maintains | Neutral | Get Alert |
05/29/2024 | Buy Now | -5.94% | Citigroup | David Hoang42% | → $8 | Initiates | → Sell | Get Alert |
05/29/2024 | Buy Now | 76.37% | Baird | Joel Beatty69% | → $15 | Initiates | → Neutral | Get Alert |
05/01/2024 | Buy Now | 229.22% | JP Morgan | Anupam Rama60% | $29 → $28 | Maintains | Overweight | Get Alert |
04/26/2024 | Buy Now | 193.94% | HC Wainwright & Co. | Douglas Tsao53% | $28 → $25 | Maintains | Neutral | Get Alert |
04/26/2024 | Buy Now | 123.4% | Goldman Sachs | Salveen Richter53% | $28 → $19 | Maintains | Neutral | Get Alert |
04/26/2024 | Buy Now | 76.37% | RBC Capital | Brian Abrahams52% | $26 → $15 | Maintains | Sector Perform | Get Alert |
04/26/2024 | Buy Now | 111.64% | Truist Securities | Joon Lee78% | $22 → $18 | Maintains | Hold | Get Alert |
04/26/2024 | Buy Now | 111.64% | Mizuho | Uy Ear63% | $20 → $18 | Maintains | Neutral | Get Alert |
04/26/2024 | Buy Now | 99.88% | Canaccord Genuity | Sumant Kulkarni45% | $21 → $17 | Maintains | Hold | Get Alert |
04/26/2024 | Buy Now | — | Needham | Ami Fadia62% | — | Reiterates | → Hold | Get Alert |
04/25/2024 | Buy Now | — | Needham | Ami Fadia62% | — | Reiterates | → Hold | Get Alert |
04/18/2024 | Buy Now | 123.4% | Scotiabank | George Farmer48% | $34 → $19 | Maintains | Sector Outperform | Get Alert |
04/18/2024 | Buy Now | 99.88% | Oppenheimer | Jay Olson62% | $25 → $17 | Maintains | Perform | Get Alert |
04/18/2024 | Buy Now | 88.12% | TD Cowen | Ritu Baral36% | $30 → $16 | Maintains | Buy | Get Alert |
04/18/2024 | Buy Now | — | Needham | Ami Fadia62% | — | Reiterates | → Hold | Get Alert |
04/17/2024 | Buy Now | 229.22% | HC Wainwright & Co. | Douglas Tsao53% | $28 → $28 | Reiterates | Neutral → Neutral | Get Alert |
04/17/2024 | Buy Now | 182.19% | Wedbush | Laura Chico48% | $24 → $24 | Reiterates | Neutral → Neutral | Get Alert |
04/17/2024 | Buy Now | 64.61% | B of A Securities | Tazeen Ahmad56% | $24 → $14 | Downgrade | Neutral → Underperform | Get Alert |
03/26/2024 | Buy Now | 240.98% | JP Morgan | Anupam Rama60% | $24 → $29 | Maintains | Overweight | Get Alert |
03/11/2024 | Buy Now | 205.7% | RBC Capital | Brian Abrahams52% | $26 → $26 | Reiterates | Sector Perform → Sector Perform | Get Alert |
02/28/2024 | Buy Now | 158.67% | Morgan Stanley | Vikram Purohit38% | $20 → $22 | Maintains | Equal-Weight | Get Alert |
02/15/2024 | Buy Now | 229.22% | HC Wainwright & Co. | Douglas Tsao53% | $25 → $28 | Maintains | Neutral | Get Alert |
02/15/2024 | Buy Now | 205.7% | RBC Capital | Brian Abrahams52% | $21 → $26 | Maintains | Sector Perform | Get Alert |
12/18/2023 | Buy Now | 135.16% | Stifel | Paul Matteis43% | $22 → $20 | Maintains | Hold | Get Alert |
12/12/2023 | Buy Now | 146.91% | Deutsche Bank | Neena Bitritto-Garg59% | → $21 | Initiates | → Hold | Get Alert |
11/08/2023 | Buy Now | 146.91% | RBC Capital | Brian Abrahams52% | $22 → $21 | Maintains | Sector Perform | Get Alert |
11/08/2023 | Buy Now | 158.67% | Wedbush | Laura Chico48% | $21 → $22 | Maintains | Neutral | Get Alert |
10/13/2023 | Buy Now | 193.94% | Goldman Sachs | Salveen Richter53% | $22 → $25 | Maintains | Neutral | Get Alert |
09/08/2023 | Buy Now | 182.19% | B of A Securities | Tazeen Ahmad56% | $25 → $24 | Maintains | Neutral | Get Alert |
09/07/2023 | Buy Now | 135.16% | Mizuho | Vamil Divan76% | $19 → $20 | Maintains | Neutral | Get Alert |
09/07/2023 | Buy Now | 158.67% | RBC Capital | Brian Abrahams52% | $25 → $22 | Maintains | Sector Perform | Get Alert |
08/09/2023 | Buy Now | 158.67% | Goldman Sachs | Salveen Richter53% | $75 → $22 | Maintains | Neutral | Get Alert |
08/09/2023 | Buy Now | 135.16% | Morgan Stanley | Vikram Purohit38% | $49 → $20 | Maintains | Equal-Weight | Get Alert |
08/08/2023 | Buy Now | 229.22% | TD Cowen | Ritu Baral36% | $105 → $28 | Maintains | Outperform | Get Alert |
08/08/2023 | Buy Now | 135.16% | Oppenheimer | Jay Olson62% | $24 → $20 | Maintains | Perform | Get Alert |
08/08/2023 | Buy Now | 193.94% | RBC Capital | Brian Abrahams52% | → $25 | Reiterates | Sector Perform → Sector Perform | Get Alert |
08/08/2023 | Buy Now | 135.16% | Truist Securities | Joon Lee78% | $40 → $20 | Maintains | Hold | Get Alert |
08/08/2023 | Buy Now | 123.4% | Mizuho | Vamil Divan76% | $45 → $19 | Maintains | Neutral | Get Alert |
08/08/2023 | Buy Now | 158.67% | Goldman Sachs | Salveen Richter53% | → $22 | Downgrade | Buy → Neutral | Get Alert |
08/08/2023 | Buy Now | 146.91% | Canaccord Genuity | Sumant Kulkarni45% | $64 → $21 | Downgrade | Buy → Hold | Get Alert |
08/08/2023 | Buy Now | — | Needham | Ami Fadia62% | — | Downgrade | Buy → Hold | Get Alert |
08/08/2023 | Buy Now | 217.46% | HC Wainwright & Co. | Douglas Tsao53% | $50 → $27 | Maintains | Neutral | Get Alert |
08/07/2023 | Buy Now | 158.67% | Stifel | Paul Matteis43% | $60 → $22 | Downgrade | Buy → Hold | Get Alert |
08/07/2023 | Buy Now | 158.67% | Wedbush | Laura Chico48% | → $22 | Downgrade | Outperform → Neutral | Get Alert |
08/07/2023 | Buy Now | 487.89% | HC Wainwright & Co. | Douglas Tsao53% | → $50 | Reiterates | Neutral → Neutral | Get Alert |
08/07/2023 | Buy Now | 193.94% | RBC Capital | Brian Abrahams52% | $71 → $25 | Downgrade | Outperform → Sector Perform | Get Alert |
08/07/2023 | Buy Now | — | Oppenheimer | Jay Olson62% | — | Downgrade | Outperform → Perform | Get Alert |
08/07/2023 | Buy Now | 723.05% | Needham | Ami Fadia62% | → $70 | Reiterates | Buy → Buy | Get Alert |
08/03/2023 | Buy Now | 476.13% | Morgan Stanley | Vikram Purohit38% | $49 → $49 | Maintains | Equal-Weight | Get Alert |
07/27/2023 | Buy Now | 617.23% | Scotiabank | George Farmer48% | → $61 | Initiates | → Sector Outperform | Get Alert |
05/23/2023 | Buy Now | 617.23% | B of A Securities | Tazeen Ahmad56% | $56 → $61 | Maintains | Buy | Get Alert |
05/23/2023 | Buy Now | 487.89% | HC Wainwright & Co. | Douglas Tsao53% | → $50 | Reiterates | Neutral → Neutral | Get Alert |
05/09/2023 | Buy Now | 476.13% | Morgan Stanley | Vikram Purohit38% | $50 → $49 | Maintains | Equal-Weight | Get Alert |
05/03/2023 | Buy Now | 558.44% | B of A Securities | Tazeen Ahmad56% | $55 → $56 | Maintains | Buy | Get Alert |
05/03/2023 | Buy Now | 476.13% | Citigroup | Neena Bitritto-Garg59% | $46 → $49 | Maintains | Neutral | Get Alert |
The latest price target for Sage Therapeutics (NASDAQ:SAGE) was reported by Scotiabank on February 12, 2025. The analyst firm set a price target for $12.00 expecting SAGE to rise to within 12 months (a possible 41.09% upside). 64 analyst firms have reported ratings in the last year.
The latest analyst rating for Sage Therapeutics (NASDAQ:SAGE) was provided by Scotiabank, and Sage Therapeutics maintained their sector outperform rating.
The last upgrade for Sage Therapeutics Inc happened on November 21, 2024 when RBC Capital raised their price target to $4. RBC Capital previously had an underperform for Sage Therapeutics Inc.
The last downgrade for Sage Therapeutics Inc happened on October 4, 2024 when RBC Capital changed their price target from $10 to $4 for Sage Therapeutics Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Sage Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Sage Therapeutics was filed on February 12, 2025 so you should expect the next rating to be made available sometime around February 12, 2026.
While ratings are subjective and will change, the latest Sage Therapeutics (SAGE) rating was a maintained with a price target of $14.00 to $12.00. The current price Sage Therapeutics (SAGE) is trading at is $8.51, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.